{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:16:49Z","timestamp":1788347809755,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.leukres.2026.108198","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:23:14Z","timestamp":1773249794000},"page":"108198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The emerging role of plasmacytoid dendritic cell proliferation in acute myeloid leukemia"],"prefix":"10.1016","volume":"164","author":[{"given":"Mariana Schmidt","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Aydos","family":"Marcondes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-5203","authenticated-orcid":false,"given":"Liane Nanci","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.leukres.2026.108198_bib1","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3390\/cancers14143545","article-title":"Plasmacytoid dendritic cells, a novel target in myeloid neoplasms","volume":"14","author":"Roussel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2026.108198_bib2","series-title":"Plasmacytoid Dendritic Cells","author":"Ganguly","year":"2022"},{"issue":"1","key":"10.1016\/j.leukres.2026.108198_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2026.108198_bib4","unstructured":"J.D. Khoury, K. Takeuchi, W. Xiao, , 2024, Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm. WHO Classification of Tumours Editorial Board. Haematolymphoid tumours, 5th ed., V. 11. Lyon (France): International Agency for Research on Cancer; 2024. https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/63\/87. Accessed June 30, 2025."},{"issue":"2","key":"10.1016\/j.leukres.2026.108198_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.leukres.2026.108198_bib6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2020007897","article-title":"Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia","volume":"137","author":"Xiao","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2026.108198_bib7","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3324\/haematol.2020.253740","article-title":"Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape","volume":"106","author":"Zalma\u00ef","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2026.108198_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-immunol-090122-041105","article-title":"Ontogeny and function of plasmacytoid dendritic cells","volume":"42","author":"Adams","year":"2024","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108198_bib9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/1097-0142(19920315)69:6<1457::AID-CNCR2820690625>3.0.CO;2-F","article-title":"Plasmacytoid monocyte proliferation associated with myeloproliferative disorders","volume":"69","author":"Baddoura","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2026.108198_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41423-024-01167-5","article-title":"The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond","volume":"21","author":"Ngo","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.leukres.2026.108198_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3389\/fimmu.2019.01222","article-title":"What makes a pDC: recent advances in understanding plasmacytoid DC development and heterogeneity","volume":"10","author":"Musumeci","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108198_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41577-020-00413-x","article-title":"Genetic models of human and mouse dendritic cell development and function","volume":"21","author":"Anderson","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108198_bib13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1365-2559.2012.04282.x","article-title":"Tumorous proliferations of plasmacytoid dendritic cells and Langerhans cells associated with acute myeloid leukaemia","volume":"61","author":"Song","year":"2012","journal-title":"Histopathology"},{"issue":"s1","key":"10.1016\/j.leukres.2026.108198_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5045\/br.2023.2023052","article-title":"Plasmacytoid dendritic cell neoplasms","volume":"58","author":"Lee","year":"2023","journal-title":"Blood Res."},{"issue":"5","key":"10.1016\/j.leukres.2026.108198_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bjh.18632","article-title":"Plasmacytoid dendritic cells in the setting of myeloid neoplasms: diagnostic guide to challenging pathologic presentations","volume":"200","author":"Hussein","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"14","key":"10.1016\/j.leukres.2026.108198_bib16","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/cancers14143375","article-title":"Immunophenotypic and molecular features of acute myeloid leukemia with plasmacytoid dendritic cell differentiation are distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.leukres.2026.108198_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cyto.a.23953","article-title":"Myeloid neoplasms with elevated plasmacytoid dendritic cell differentiation reflect the maturation process of dendritic cells","volume":"97","author":"Huang","year":"2019","journal-title":"Cytom. Part A"},{"issue":"1","key":"10.1016\/j.leukres.2026.108198_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cyto.b.21761","article-title":"Flow cytometry identifies a spectrum of maturation in myeloid neoplasms having plasmacytoid dendritic cell differentiation","volume":"98","author":"Hamadeh","year":"2020","journal-title":"Cytom. Part B Clin. Cytom."},{"issue":"11","key":"10.1016\/j.leukres.2026.108198_bib19","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/cancers16112118","article-title":"Flow cytometry profiling of plasmacytoid dendritic cell neoplasms","volume":"16","author":"Hussein","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2026.108198_bib20","unstructured":"Jiang L.J., Chen X. International clinical cytometry society. \u3008https:\/\/www.cytometry.org\/web\/q_view.php?id=580&filter=Interpretation%20and%20Clinical%20Application\u3009. Accessed October 20, 2025."},{"key":"10.1016\/j.leukres.2026.108198_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749190","article-title":"The role of plasmacytoid dendritic cells in cancers","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.leukres.2026.108198_bib22","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood.V98.13.3750","article-title":"Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment","volume":"98","author":"Mohty","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2026.108198_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1189\/jlb.0411190","article-title":"Plasmacytoid dendritic cells and cancer","volume":"90","author":"Vermi","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.leukres.2026.108198_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.18632\/oncotarget.27949","article-title":"Activation of plasmacytoid dendritic cells promotes AML-cell fratricide","volume":"12","author":"Fatehchand","year":"2021","journal-title":"Oncotarget"},{"issue":"s1","key":"10.1016\/j.leukres.2026.108198_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/eci.12363","article-title":"Plasmacytoid dendritic cells, a role in neoplastic prevention and progression","volume":"45","author":"Lombardi","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.leukres.2026.108198_bib26","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1537-2995.2009.02170.x","article-title":"Immunophenotypical, morphologic, and functional characterization of maturation-associated plasmacytoid dendritic cell subsets in normal adult human bone marrow","volume":"49","author":"Mart\u00edn-Mart\u00edn","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.leukres.2026.108198_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"17","key":"10.1016\/j.leukres.2026.108198_bib28","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3390\/cancers14174132","article-title":"Genetics and epigenetics in neoplasms with plasmacytoid dendritic cells","volume":"14","author":"Renosi","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.leukres.2026.108198_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/BS9.0000000000000097","article-title":"Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells","volume":"4","author":"Gong","year":"2022","journal-title":"Blood Sci."},{"issue":"15","key":"10.1016\/j.leukres.2026.108198_bib30","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1158\/1078-0432.CCR-14-2203","article-title":"Biological activities of RUNX1 mutants predict secondary acute leukemia transformation from chronic myelomonocytic leukemia and myelodysplastic syndromes","volume":"21","author":"Tsai","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.leukres.2026.108198_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3324\/haematol.2020.247569","article-title":"Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm","volume":"106","author":"Wang","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2026.108198_bib32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2019.01088","article-title":"Human dendritic cell subsets, ontogeny, and impact on HIV infection","volume":"10","author":"Rhodes","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108198_bib33","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108198_bib34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41590-023-01545-7","article-title":"Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses","volume":"24","author":"Sulczewski","year":"2023","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108198_bib35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1600-0560.2011.01777.x","article-title":"Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"38","author":"Dargent","year":"2011","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.leukres.2026.108198_bib36","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.2147\/CMAR.S260825","article-title":"Plasmacytoid dendritic cell infiltration in acute myeloid leukemia","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"7","key":"10.1016\/j.leukres.2026.108198_bib37","first-page":"7285","article-title":"Tumor-forming plasmacytoid dendritic cells in acute myelocytic leukemia: a report of three cases and literature review","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp."},{"issue":"10","key":"10.1016\/j.leukres.2026.108198_bib38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.2020008745","article-title":"Targeting the p-D-C: easy as C-D-1-2-3?","volume":"137","author":"Pemmaraju","year":"2020","journal-title":"Blood"},{"issue":"s1","key":"10.1016\/j.leukres.2026.108198_bib39","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2023-186126","article-title":"Analysis of tagraxofusp activity in AML-Pdc as a single agent and in combination with BCL2 inhibitors","volume":"142","author":"Boichut","year":"2023","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.leukres.2026.108198_bib40","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/cncr.35315","article-title":"Tagraxofusp, a first-in-class CD123-targeted agent: five-year postapproval comprehensive review of the literature","volume":"130","author":"Jen","year":"2024","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2026.108198_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/hon.3234","article-title":"Tagraxofusp in myeloid malignancies","volume":"42","author":"Bruzzese","year":"2023","journal-title":"Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108198_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2025.100066","article-title":"New leads to enhance tagraxofusp efficacy in pDC-AML","volume":"2","author":"Boichut","year":"2025","journal-title":"Blood Neoplasia"},{"issue":"3","key":"10.1016\/j.leukres.2026.108198_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/bloodadvances.2023011721","article-title":"Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leucemia","volume":"8","author":"Lane","year":"2024","journal-title":"Blood Adv."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:00:32Z","timestamp":1776225632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0145212626000421"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108198","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of plasmacytoid dendritic cell proliferation in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108198"}}